DN
DNA Group (T.R.) Ltd.
DNA | TA
Overview
Corporate Details
- ISIN(s):
- IL0011038523
- LEI:
- Country:
- Israel
- Address:
- Shimon Hatars' 43, 6249245 Tel Aviv
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
DNA Group develops and markets technological solutions for defense and homeland security sectors.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2022-11-06 14:35 |
Regulatory News Service
Changes in the company's names and security names , effective as of f November …
|
Hebrew (modern) | 149.0 KB | |
| 2021-07-29 21:13 |
Regulatory News Service
Termination of coverage report
|
Hebrew (modern) | 174.5 KB | |
| 2021-07-29 21:13 |
Related Party Transactions
Termination of coverage report
|
Russian | 101.2 KB | |
| 2021-06-13 10:10 |
Business and Financial Review
update Analysis (FROST) following financial report, target price remains at NIS…
|
English | 1.1 MB | |
| 2021-06-13 10:10 |
Transaction in Own Shares
update Analysis (FROST) following financial report, target price remains at NIS…
|
Russian | 101.2 KB | |
| 2021-04-11 22:23 |
Regulatory News Service
update Analysis (FROST) following financial report 2020,target price remains at…
|
English | 1.1 MB | |
| 2021-04-11 22:23 |
Major Shareholding Notification
update Analysis (FROST) following financial report 2020,target price remains at…
|
Russian | 98.1 KB | |
| 2020-12-16 19:22 |
Regulatory News Service
Analysis update following financial report:price target is unchanged NIS 2.62
|
English | 1.1 MB | |
| 2020-12-16 19:22 |
Major Shareholding Notification
Analysis update following financial report:price target is unchanged NIS 2.62
|
Russian | 94.7 KB | |
| 2020-09-01 21:58 |
Business and Financial Review
Analysis update following financial report:price target is unchanged NIS 2.62
|
English | 1.1 MB | |
| 2020-09-01 21:58 |
Major Shareholding Notification
Analysis update following financial report:price target is unchanged NIS 2.62
|
Russian | 94.7 KB | |
| 2020-08-24 21:06 |
Quarterly Report
update analsis (FORST),price target is unchanged
|
English | 1.1 MB | |
| 2020-08-24 21:06 |
Inside Information Statement
update analsis (FORST),price target is unchanged
|
Russian | 91.4 KB | |
| 2020-06-10 21:16 |
Investor Presentation
Quarterly analysis update report
|
English | 1.1 MB | |
| 2020-06-10 21:16 |
Declaration of Voting Results & Voting Rights Announcements
Quarterly analysis update report
|
Russian | 93.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
BSF ENTERPRISE PLC | United Kingdom | BSFA | |
|
Can-Fite BioPharma Ltd. | Israel | CANF | |
|
Cantargia | Sweden | CANTA | |
|
Captor Therapeutics S.A. | Poland | CTX | |
|
Carbiotix AB | Sweden | CRBX | |
|
Cellectis | France | ALCLS | |
|
CELLULAR GOODS PLC | United Kingdom | CBX | |
|
Celyad Oncology SA | Belgium | CYAD | |
|
Cereno Scientific AB | Sweden | CRNO | |
|
Cessatech A/S | Denmark | CESSA |